Linking cell function with perfusion: insights from the transcatheter delivery of bone marrow-derived CD133 cells in ischemic refractory cardiomyopathy trial (RECARDIO)

about

Linking cell function with perfusion: insights from the transcatheter delivery of bone marrow-derived CD133 cells in ischemic refractory cardiomyopathy trial (RECARDIO)

Item

http://www.wikidata.org/entity/Q58741622

description

im September 2018 veröffentlicher wissenschaftlicher Artikel

@de

scientific article published on 14 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Linking cell function with per ...... ardiomyopathy trial (RECARDIO)

@en

Linking cell function with per ...... efractory cardiomyopathy trial

@nl

type

Item

label

Linking cell function with per ...... ardiomyopathy trial (RECARDIO)

@en

Linking cell function with per ...... efractory cardiomyopathy trial

@nl

prefLabel

Linking cell function with per ...... ardiomyopathy trial (RECARDIO)

@en

Linking cell function with per ...... efractory cardiomyopathy trial

@nl

P1476

Linking cell function with per ...... ardiomyopathy trial (RECARDIO)

@en

P2093

Alberto Bestetti

http://www.w3.org/2001/XMLSchema#string

Alice Bonomi

http://www.w3.org/2001/XMLSchema#string

Beatrice Bassetti

http://www.w3.org/2001/XMLSchema#string

Daniela Belotti

http://www.w3.org/2001/XMLSchema#string

Elisa Gambini

http://www.w3.org/2001/XMLSchema#string

Fabrizio Celeste

http://www.w3.org/2001/XMLSchema#string

Felice Achilli

http://www.w3.org/2001/XMLSchema#string

Giuseppe Gaipa

http://www.w3.org/2001/XMLSchema#string

Lorenza Biava

http://www.w3.org/2001/XMLSchema#string

Matteo Parma

http://www.w3.org/2001/XMLSchema#string

P2860

Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2

Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor

Impact of Cell Therapy on Myocardial Perfusion and Cardiovascular Outcomes in Patients With Angina Refractory to Medical Therapy: A Systematic Review and Meta-Analysis.

Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.

Meta-analysis of stem cell therapy in chronic ischemic cardiomyopathy.

Bone Marrow Stem Cell Treatment for Ischemic Heart Disease in Patients with No Option of Revascularization: A Systematic Review and Meta-Analysis.

Fatality, morbidity and quality of life in patients with refractory angina pectoris.

Predictors of long-term clinical endpoints in patients with refractory angina

Predictors of response to intramyocardial bone marrow cell treatment in patients with refractory angina and chronic myocardial ischemia.

Extracorporeal shockwave myocardial therapy is efficacious in improving symptoms in patients with refractory angina pectoris--a multicenter study.

P2888

s13287-018-0969-z

P304

235

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13287-018-0969-Z

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Piergiuseppe Agostoni

P577

2018-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1106947602

http://www.w3.org/2001/XMLSchema#string

P698

30217223

http://www.w3.org/2001/XMLSchema#string

P921

molecular medicine

P932

6137884

http://www.w3.org/2001/XMLSchema#string